Ellagic acid enhances morphine analgesia and attenuates the development of morphine tolerance and dependence in mice
- 1 October 2014
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 741, 272-280
Abstract
No abstract availableKeywords
Funding Information
- Physiology Research Center (PRC-115)
This publication has 42 references indexed in Scilit:
- Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cellsJournal of Vascular Surgery, 2010
- Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndromeBehavioural Pharmacology, 2007
- Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acidJournal of Pharmacy and Pharmacology, 2006
- Comparative effects of cyclo‐oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid toleranceBritish Journal of Pharmacology, 1999
- EFFICIENT DESIGNS FOR STUDYING SYNERGISTIC DRUG COMBINATIONSLife Sciences, 1997
- Opioid AnalgesicsDrugs, 1996
- Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in miceNeuropharmacology, 1994
- Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl esterLife Sciences, 1993
- Statistical analysis of drug-drug and site-site interactions with isobologramsLife Sciences, 1989
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983